Therapy News and Research

RSS

NYU Steinhardt creates Marilyn Moffat Endowed Chair in Physical Therapy to support faculty member

NYU's Steinhardt School of Culture, Education, and Human Development has created the Marilyn Moffat Endowed Chair in Physical Therapy to support a faculty member dedicated to advancing physical therapy through research, teaching, and practice.

24 Jun 2015

Breast cancer treatment market estimated to increase to over $13.1 billion by 2020

Analysis from business intelligence provider GBI Research - Breast Cancer Therapeutics in Major Developed Markets to 2020 - forecasts the breast cancer treatment market to increase in value from $9.2 billion in 2013 to more than $13.1 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.1%.

24 Jun 2015

Dutch investigators report on long-term outcome of psychotherapy study in diabetes

In the last issue of Psychotherapy and Psychosomatic, a group of Dutch investigators headed by professor Paul Emmelkamp reports on the long-term outcome of a psychotherapy study in diabetes.

24 Jun 2015

Life-saving defibrillators are grossly underutilized, shows study

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association.

24 Jun 2015

IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due to macular oedema that follows blockage of branch veins of the central retinal vein (branch retinal vein occlusion, BRVO).

24 Jun 2015

Johns Hopkins scientists use experimental therapy to reverse progression of atherosclerosis in rodents

In what may be a major leap forward in the quest for new treatments of the most common form of cardiovascular disease, scientists at Johns Hopkins report they have found a way to halt and reverse the progression of atherosclerosis in rodents by loading microscopic nanoparticles with a chemical that restores the animals’ ability to properly handle cholesterol.

24 Jun 2015

Discovery may accelerate development of new drugs to treat Huntington's disease

By identifying in spinal fluid how the characteristic mutant proteins of Huntington's disease spread from cell to cell, UC Irvine scientists and colleagues have created a new method to quickly and accurately track the presence and proliferation of these neuron-damaging compounds -- a discovery that may accelerate the development of new drugs to treat this incurable disease.

24 Jun 2015

PolyU develops novel big data analysis platform for analyzing interactions among cancer genes

The Hong Kong Polytechnic University has achieved a breakthrough in the cancer genomics by developing a novel big data analysis platform for analyzing the interactions among genes. The analysis platform unveils the unregulated patterns of gene network in cancer and discovers potential diagnostic and therapeutic target genes, Nucleophosmin (NPM1) and its associated genes, in Chronic Myelogenous Leukemia (CML).

24 Jun 2015

'Virtual-reality' therapy can reduce people's craving for alcohol, new study suggests

A form of 'virtual-reality' therapy may help people with alcohol dependence reduce their craving for alcohol, a new study suggests. The findings, published in the July issue of the Journal of Studies on Alcohol and Drugs, come from a small study of just 10 patients.

24 Jun 2015

Perle Bioscience announces enrollment for Phase 3 trial of combination therapy in type 1 diabetics

Perle Bioscience, Inc. announces enrollment for the Insulin Independence Trial (IIT). This trial is the first and only Phase 3 trial to test a combination therapy in type 1 diabetics.

24 Jun 2015

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

23 Jun 2015

Current treatments for blood cancer priced too high to be considered cost-effective, new analysis finds

The costs associated with cancer drug prices have risen dramatically over the past 15 years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.

23 Jun 2015

Statins benefit patients undergoing major lung resection, lower major complications

Statins have been shown to reduce complications from cardiovascular surgery. To determine whether statins might also help those undergoing major lung surgeries, a team at Memorial Sloan Kettering Cancer Center conducted a well-designed study that randomized patients to receive either a statin or placebo before and after surgery.

23 Jun 2015

Israeli researchers establish novel optogenetic method for cardiac pacing and resynchronization

Israeli researchers have successfully established a new approach for pacing the heart and synchronizing its mechanical activity without the use of a conventional electrical pacemaker. This novel biologic strategy employs light-sensitive genes that can be injected into the heart and then activated by flashes of blue light.

23 Jun 2015

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators may be underestimating device problems, according to UC San Francisco researchers who propose systematic methods to determine accurate causes of sudden death in those with CIEDs as well as improved monitoring for device concerns.

23 Jun 2015

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

Patients with atrial fibrillation who stopped taking blood thinners before they had elective surgery had no higher risk of developing blood clots and less risk of major bleeding compared to patients who were given a "bridge" therapy, according to research led by Duke Medicine.

23 Jun 2015

Ontario announces $25 million investment to support new treatments for people with chronic diseases

Ontario is investing $25 million over five years to support new treatments and therapies for people living with chronic diseases, such as cancer, multiple sclerosis and diabetes.

23 Jun 2015

PSMA can be an ideal target for diagnosis and treatment of prostate cancer

Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells, but is found at much higher levels on prostate cancer cells. It is barely found in the rest of the body. "Therefore, PSMA is an ideal target for diagnostic purposes as well as targeted therapies against prostate cancer," says biotechnologist Dr. Matthias Eder of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).

23 Jun 2015

Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis

Patients with progressive multiple sclerosis and their clinicians see clear improvements during treatment with a high dose of biotin, show further results from the phase III trial of the therapy.

22 Jun 2015

VG Life Sciences receives U.S. patent for combination cancer therapy

VG Life Sciences, Inc., a biotechnology company developing therapies for cancer, autoimmune and infectious diseases, announced that the U.S. Patent and Trademark Office will issue Patent No. 9073985 covering VGLS' combination therapy for treating drug-resistant cancer by combining an autophagy inhibitor with a chemotherapy drug.

22 Jun 2015

Therapy News and Research

NYU Steinhardt creates Marilyn Moffat Endowed Chair in Physical Therapy to support faculty member

Breast cancer treatment market estimated to increase to over $13.1 billion by 2020

Dutch investigators report on long-term outcome of psychotherapy study in diabetes

Life-saving defibrillators are grossly underutilized, shows study

IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

Johns Hopkins scientists use experimental therapy to reverse progression of atherosclerosis in rodents

Discovery may accelerate development of new drugs to treat Huntington's disease

PolyU develops novel big data analysis platform for analyzing interactions among cancer genes

'Virtual-reality' therapy can reduce people's craving for alcohol, new study suggests

Perle Bioscience announces enrollment for Phase 3 trial of combination therapy in type 1 diabetics

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

Current treatments for blood cancer priced too high to be considered cost-effective, new analysis finds

Statins benefit patients undergoing major lung resection, lower major complications

Israeli researchers establish novel optogenetic method for cardiac pacing and resynchronization

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

Ontario announces $25 million investment to support new treatments for people with chronic diseases

PSMA can be an ideal target for diagnosis and treatment of prostate cancer

Biotin benefits ‘clinically relevant’ in progressive multiple sclerosis

VG Life Sciences receives U.S. patent for combination cancer therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News